Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
J Exp Med (1992) 175 (5): 1345–1352.
Currently there are no citedby results. Try again later.
